301230 泓博醫藥
按盤價 
30.160 -0.720 (-2.332%)
30.160 -0.720 (-2.332%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.152 | 1.589 | 3.373 | 9.194 | 24.060 |
| 總資產報酬率 ROA (%) | 0.904 | 1.219 | 2.698 | 7.227 | 16.206 |
| 投入資產回報率 ROIC (%) | 0.969 | 1.329 | 2.925 | 7.847 | 18.619 | 邊際利潤分析 |
| 銷售毛利率 (%) | 28.389 | 23.864 | 30.875 | 36.874 | 38.688 |
| 營業利潤率 (%) | 6.563 | 0.667 | 7.646 | 15.211 | 19.336 |
| 息稅前利潤/營業總收入 (%) | 6.764 | 0.830 | 7.388 | 13.687 | 20.267 |
| 淨利潤/營業總收入 (%) | 7.067 | 3.138 | 7.682 | 14.028 | 16.416 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.654 | -261.844 | 107.784 | 95.280 | 100.765 |
| 價值變動淨收益/利潤總額(%) | 16.550 | 237.822 | 16.890 | 0.691 | 2.551 |
| 營業外收支淨額/利潤總額(%) | -0.539 | -2.769 | -1.854 | 0.105 | -0.501 | 償債能力分析 |
| 流動比率 (X) | 4.359 | 4.420 | 3.824 | 9.284 | 2.154 |
| 速動比率 (X) | 3.852 | 3.870 | 3.503 | 8.778 | 1.791 |
| 資產負債率 (%) | 21.410 | 21.553 | 24.854 | 14.476 | 37.534 |
| 帶息債務/全部投入資本 (%) | 3.543 | 3.139 | 3.369 | 2.505 | 10.776 |
| 股東權益/帶息債務 (%) | 2,379.349 | 2,675.380 | 2,473.390 | 3,608.381 | 672.302 |
| 股東權益/負債合計 (%) | 367.070 | 363.973 | 302.350 | 590.777 | 166.427 |
| 利息保障倍數 (X) | 28.579 | 4.595 | -61.885 | -8.885 | 19.715 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 59.214 | 60.889 | 61.593 | 64.138 | 52.308 |
| 存貨周轉天數 (天) | 50.823 | 56.649 | 59.822 | 58.265 | 70.563 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 07/05/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
